Foster Group
ABBV icon

Foster Group’s AbbVie ABBV Stock Holding History

Foster Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.42M Sell
9,244
-359
-4% -$92K 0.07% 83
2026
Q2 		$2.42M Buy
9,603
+375
+4% +$80.7K 0.06% 83
2026
Q1 		$2.01M Buy
9,228
+748
+9% +$166K 0.06% 82
2025
Q4 		$1.94M Buy
8,480
+258
+3% +$58.8K 0.06% 81
2025
Q3 		$1.9M Buy
8,222
+101
+1% +$20.6K 0.06% 80
2025
Q2 		$1.51M Buy
8,121
+220
+3% +$40.9K 0.05% 83
2025
Q1 		$1.66M Buy
7,901
+719
+10% +$140K 0.06% 71
2024
Q4 		$1.28M Sell
7,182
-1,162
-14% -$214K 0.05% 73
2024
Q3 		$1.65M Sell
8,344
-2
-0% -$373 0.06% 68
2024
Q2 		$1.43M Buy
8,346
+164
+2% +$27.2K 0.06% 77
2024
Q1 		$1.49M Buy
8,182
+547
+7% +$94.3K 0.07% 71
2023
Q4 		$1.14M Hold
7,635
– – 0.07% 69
2023
Q3 		$1.14M Buy
7,635
+743
+11% +$109K 0.07% 69
2023
Q2 		$929K Sell
6,892
-715
-9% -$105K 0.06% 77
2023
Q1 		$1.21M Buy
7,607
+576
+8% +$88.1K 0.08% 64
2022
Q4 		$1.14M Buy
7,031
+310
+5% +$47.5K 0.08% 60
2022
Q3 		$902K Buy
6,721
+245
+4% +$35.2K 0.07% 60
2022
Q2 		$992K Sell
6,476
-253
-4% -$38.7K 0.07% 63
2022
Q1 		$1.09M Buy
6,729
+406
+6% +$59K 0.09% 58
2021
Q4 		$856K Sell
6,323
-68
-1% -$8.03K 0.07% 65
2021
Q3 		$689K Sell
6,391
-176
-3% -$20.1K 0.07% 70
2021
Q2 		$740K Buy
6,567
+73
+1% +$8.22K 0.09% 69
2021
Q1 		$703K Sell
6,494
-65
-1% -$6.95K 0.11% 57
2020
Q4 		$679K Buy
+6,559
New +$630K 0.13% 47

Other funds holding ABBV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Foster Group's ABBV Position: Q3 2026 in Review

Foster Group reduced its AbbVie (ABBV) stake by 3.7% in Q3 2026, selling an estimated $92K and leaving 9,244 shares worth $2.42M. The position accounts for 0.07% of the portfolio, ranked #83.

Foster Group first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. 902 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Foster Group held 9,244 shares of AbbVie worth $2.42M as of Q3 2026.
  • Foster Group sold 359 AbbVie shares in Q3 2026, an estimated $92K.
  • AbbVie made up 0.07% of Foster Group's portfolio in Q3 2026, its #83 holding.
  • Foster Group first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • 902 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.